Nicholas Donoghoe insider trades
Open-market stock purchases and sales by Nicholas Donoghoe, EVP, CHIEF BUS/STRAT OFFICER at AbbVie Inc, from SEC Form 4 filings since Jan 2, 2019.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +296%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 14, 2026 | ABBV AbbVie Inc | Sold | $8.2M |
| Aug 14, 2026 | ABBV AbbVie Inc | Bought (not open market) | — |
| Feb 27, 2026 | ABBV AbbVie Inc | Sold (not open market) | $3M |
| Feb 18, 2026 | ABBV AbbVie Inc | Bought (not open market) | — |
| Feb 18, 2026 | ABBV AbbVie Inc | Bought (not open market) | — |
| Feb 18, 2026 | ABBV AbbVie Inc | Bought (not open market) | — |
| Feb 18, 2026 | ABBV AbbVie Inc | Bought (not open market) | — |
| Feb 18, 2026 | ABBV AbbVie Inc | Bought (not open market) | — |
Companies traded
- ABBV AbbVie Inc: 1 buy, 5 sales, last Aug 14, 2026